Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 44.0% in August

Posted by on Aug 26th, 2023

Ainos, Inc. (NASDAQ:AIMD – Get Free Report) saw a large decrease in short interest in the month of August. As of August 15th, there was short interest totalling 82,100 shares, a decrease of 44.0% from the July 31st total of 146,600 shares. Based on an average daily volume of 242,700 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.3% of the company’s shares are short sold.

Ainos Stock Performance

Shares of NASDAQ AIMD opened at $0.62 on Friday. The company has a market cap of $12.48 million, a P/E ratio of -0.72 and a beta of 1.02. The company has a quick ratio of 1.45, a current ratio of 1.92 and a debt-to-equity ratio of 0.08. Ainos has a 52-week low of $0.55 and a 52-week high of $2.36.

Ainos Company Profile

(Get Free Report)

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.

Featured Articles

Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.